EMvision Historical Cash Flow
| EMV Stock | 1.98 0.02 1.02% |
Analysis of EMvision Medical cash flow over time is an excellent tool to project EMvision Medical Devices future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 5.8 M or Depreciation of 228.1 K as it is a great indicator of EMvision Medical ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining EMvision Medical Devices latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether EMvision Medical Devices is a good buy for the upcoming year.
EMvision |
About EMvision Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in EMvision balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which EMvision's non-liquid assets can be easily converted into cash.
EMvision Medical Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by EMvision Medical Devices to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of EMvision Medical operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from EMvision Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into EMvision Medical Devices current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EMvision Medical Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, EMvision Medical's Change In Cash is comparatively stable compared to the past year. Net Borrowings is likely to gain to about 3.1 M in 2024, despite the fact that Change In Working Capital is likely to grow to (4.4 M).
EMvision Medical cash flow statement Correlations
Click cells to compare fundamentals
EMvision Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EMvision Medical cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 4.3M | 9.0M | 1.3M | (5.7K) | (5.2K) | (4.9K) | |
| Change In Cash | 1.0M | 4.3M | (2.9M) | 3.2M | 8.7M | 9.1M | |
| Free Cash Flow | (3.3M) | (4.6M) | (4.0M) | 646.9K | (6.3M) | (6.0M) | |
| Change In Working Capital | 105.0K | (144.1K) | 197.0K | 2.4M | (4.7M) | (4.4M) | |
| Begin Period Cash Flow | 4.4M | 5.4M | 9.7M | 6.8M | 9.9M | 5.8M | |
| Other Cashflows From Financing Activities | 4.3M | (127.3K) | (175.1K) | (221.2K) | (244.5K) | (232.2K) | |
| Other Non Cash Items | 86.2K | 4.2M | 2.3M | 2.5M | 1.4M | 1.7M | |
| Total Cash From Operating Activities | (3.3M) | (4.5M) | (3.8M) | 834.2K | (6.0M) | (5.7M) | |
| Change To Operating Activities | 75.7K | (90.9K) | 108.4K | (671.0) | (771.65) | (810.23) | |
| Net Income | (3.5M) | (8.4M) | (6.1M) | (3.9M) | (2.7M) | (2.9M) | |
| Total Cash From Financing Activities | 4.3M | 8.9M | 1.1M | 2.5M | 15.0M | 15.8M | |
| End Period Cash Flow | 5.4M | 9.7M | 6.8M | 10.0M | 18.6M | 19.5M | |
| Change To Netincome | 115.4K | 3.9M | 1.9M | 1.9M | 2.2M | 1.7M | |
| Change To Liabilities | (21.2K) | (53.2K) | 41.0K | 2.4M | 2.7M | 2.8M | |
| Stock Based Compensation | 115.4K | 3.9M | 1.9M | 1.9M | 874.0K | 1.7M | |
| Issuance Of Capital Stock | 4.3M | 9.0M | 1.3M | (5.7K) | 15.2M | 16.0M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for EMvision Stock Analysis
When running EMvision Medical's price analysis, check to measure EMvision Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMvision Medical is operating at the current time. Most of EMvision Medical's value examination focuses on studying past and present price action to predict the probability of EMvision Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMvision Medical's price. Additionally, you may evaluate how the addition of EMvision Medical to your portfolios can decrease your overall portfolio volatility.